VistaGen Therapeutics, Inc.

Quick facts

Phase 3 pipeline

• Fasedienol Nasal Spray · Psychiatry / Neurology
  Fasedienol is a NMDA receptor antagonist administered as a nasal spray for rapid-onset treatment of depression.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• VistaGen Therapeutics, Inc. portfolio CI brief
• VistaGen Therapeutics, Inc. pipeline updates RSS